You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis

  • Technology appraisal guidance
  • Reference number: TA199
  • Published:  25 August 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

NICE improves access to drug treatments for psoriatic arthritis

2010/120 NICE improves access to drug treatments for psoriatic arthritis

2010/120 NICE improves access to drug treatments for psoriatic arthritis2010/120 NICE improves access to drug treatments for psoriatic arthritis
24 August 2010
(59.76 Kb 17 sec @ 28.8Kbps)
Adobe Acrobat reader required.

 Adobe Acrobat reader required.

Back to top